Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	261	59	90	70	99	-
Market Cap Growth	375.42%	-35.03%	29.73%	-29.98%	-	-
Enterprise Value	215	28	64	31	46	-
Last Close Price	5.38	1.67	4.56	3.52	5.02	-
PS Ratio	60.56	8.22	8.03	54.32	169174.86	-
PB Ratio	7.97	2.82	5.50	2.12	1.90	-
P/TBV Ratio	7.97	2.82	5.50	2.12	1.90	-
EV/Sales Ratio	49.97	3.92	5.73	24.39	78418.50	-
Asset Turnover	0.10	0.25	0.29	0.03	0	-
Quick Ratio	3.40	4.01	2.16	3.27	21.04	5.10
Current Ratio	3.40	4.06	2.19	3.39	21.68	5.12
Return on Equity (ROE)	-58.27%	-86.68%	-66.66%	-45.72%	-42.00%	-52.04%
Return on Assets (ROA)	-27.79%	-36.55%	-27.94%	-23.95%	-24.36%	-26.77%
Return on Capital (ROIC)	-37.90%	-56.78%	-43.44%	-28.46%	-26.25%	-32.59%
Earnings Yield	-7.18%	-27.49%	-18.18%	-27.96%	-13.21%	-
Buyback Yield / Dilution	-77.56%	-59.89%	0.40%	-23.97%	-32.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.